Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Xuechun Yuan, Hui Lu, Anpeng Zhao, Yidan Ding, Qiong Min & Rong Wang. (2020) Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. Drug Metabolism Reviews 52:2, pages 225-234.
Read now
Read now
M. José Gómez-Lechón, Laia Tolosa & M. Teresa Donato. (2017) Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 137-148.
Read now
Read now
Petra Matoulková, Petr Pávek, Josef Malý & Jiří Vlček. (2014) Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction. Expert Opinion on Drug Metabolism & Toxicology 10:3, pages 425-435.
Read now
Read now
Zdenek Dvorak & Peotr Pavek. (2010) Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. Drug Metabolism Reviews 42:4, pages 621-635.
Read now
Read now
M. Miura, K. Inoue, H. Kagaya, M. Saito, T. Habuchi & S. Satoh. (2009) Inter-individual difference determinant of prednisolone pharmacokinetics for Japanese renal transplant recipients in the maintenance stage. Xenobiotica 39:12, pages 939-945.
Read now
Read now
Yi-Tong Liu, Hai-Ping Hao, Chang-Xiao Liu, Guang-Ji Wang & Hong-Guang Xie. (2007) Drugs as CYP3A Probes, Inducers, and Inhibitors. Drug Metabolism Reviews 39:4, pages 699-721.
Read now
Read now
Jos V Castell, Ramiro Jover, Celia P Martnez-Jimnez & Mara Jos Gmez-Lechn. (2006) Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 2:2, pages 183-212.
Read now
Read now
Lesley A. Stanley, Brian C. Horsburgh, Jillian Ross, Nico Scheer & C. Roland Wolf. (2006) PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical Toxicity. Drug Metabolism Reviews 38:3, pages 515-597.
Read now
Read now
G. Gordon Gibson, Anna Phillips, Sihem Aouabdi, Kate Plant & Nick Plant. (2006) Transcriptional Regulation of the Human Pregnane-X Receptor. Drug Metabolism Reviews 38:1-2, pages 31-49.
Read now
Read now
G. G. Gibson, N. J. Plant, K. E. Swales, A. Ayrton & W. El-Sankary. (2002) Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:3, pages 165-206.
Read now
Read now
Articles from other publishers (45)
Mahmoud Al‐Kofahi, William S. Oetting, David P. Schladt, Rory P. Remmel, Weihua Guan, Baolin Wu, Casey R. Dorr, Roslyn B. Mannon, Arthur J. Matas, Ajay K. Israni & Pamala A. Jacobson. (2021) Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry. The Journal of Clinical Pharmacology 61:8, pages 1035-1044.
Crossref
Crossref
Madhav Sachar, Edward J. Kelly & Jashvant D. Unadkat. (2019) Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells. The AAPS Journal 21:3.
Crossref
Crossref
K Sanghavi, R C Brundage, M B Miller, D P Schladt, A K Israni, W Guan, W S Oetting, R B Mannon, R P Remmel, A J Matas & P A Jacobson. (2015) Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. The Pharmacogenomics Journal 17:1, pages 61-68.
Crossref
Crossref
Tiong Chai Seah, Yea Lu Tay, Heng Kean Tan, Tengku Sifzizul Tengku Muhammad, Habibah Abdul Wahab & Mei Lan Tan. (2015) Determination of CYP3A4 Inducing Properties of Compounds Using a Laboratory-Developed Cell-Based Assay. International Journal of Toxicology 34:5, pages 454-468.
Crossref
Crossref
Catherine Marcucci, Jerusha Taylor, Ansgar M. Brambrink & Neil B. Sandson. 2015. A Case Approach to Perioperative Drug-Drug Interactions. A Case Approach to Perioperative Drug-Drug Interactions
611
614
.
Eva Tydén, Hans Tjälve & Pia Larsson. (2014) Gene and protein expression and cellular localisation of cytochrome P450 enzymes of the 1A, 2A, 2C, 2D and 2E subfamilies in equine intestine and liver. Acta Veterinaria Scandinavica 56:1.
Crossref
Crossref
E. TYDÉN, M. LÖFGREN, S. PEGOLO, F. CAPOLONGO, H. TJÄLVE & P. LARSSON. (2012) Differential gene expression of CYP3A isoforms in equine liver and intestines. Journal of Veterinary Pharmacology and Therapeutics 35:6, pages 588-595.
Crossref
Crossref
Brad Larson, Timothy Moeller, Peter Banks & James J. Cali. (2011) Automated Triplexed Hepatocyte-Based Viability and CYP1A and -3A Induction Assays. SLAS Discovery 16:8, pages 895-902.
Crossref
Crossref
Tadeja Rezen, Damjana Rozman, Jean-Marc Pascussi & Katalin Monostory. (2011) Interplay between cholesterol and drug metabolism. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1814:1, pages 146-160.
Crossref
Crossref
Chunna Yu, Shanshan Ye, Hongying Sun, Yao Liu, Lingbo Gao, Chaofeng Shen, Shuqing Chen & Su Zeng. (2009) PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chemico-Biological Interactions 177:1, pages 58-64.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
Crossref
S. Harmsen, A. S. Koster, J. H. Beijnen, J. H. M. Schellens & I. Meijerman. (2008) Comparison of Two Immortalized Human Cell Lines to Study Nuclear Receptor-Mediated CYP3A4 Induction. Drug Metabolism and Disposition 36:6, pages 1166-1171.
Crossref
Crossref
Rucha S. Sane, Donna J. Buckley, Arthur R. Buckley, Srikanth C. Nallani & Pankaj B. Desai. (2008) Role of Human Pregnane X Receptor in Tamoxifen- and 4-Hydroxytamoxifen-Mediated CYP3A4 Induction in Primary Human Hepatocytes and LS174T Cells. Drug Metabolism and Disposition 36:5, pages 946-954.
Crossref
Crossref
P Martin, R Riley, D J Back & A Owen. (2009) Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. British Journal of Pharmacology 153:4, pages 805-819.
Crossref
Crossref
G. Scott GroverTimothy G. BraymanRichard L. VoormanJoseph A. Ware. (2007)
Development of
In Vitro
Methods to Predict Induction of CYP1A2 and CYP3A4 in Humans
. ASSAY and Drug Development Technologies 5:6, pages 793-804.
Crossref
Crossref
Jimmy Jose, Kavitha Saravu & Barkur Anathakrishna Shastry. (2007) Aearly-onset rhabdomyolysis in a patient with nephrotic syndrome. American Journal of Health-System Pharmacy 64:7, pages 726-729.
Crossref
Crossref
Mohammed Al-Dosari, Guisheng Zhang, Joseph E. Knapp & Dexi Liu. (2006) Direct Assessment of Promoter Activity of Human Cytochrome P450 Genes Using Optimized Transfection in Vitro and in Vivo. Bioscience Reports 26:3, pages 217-229.
Crossref
Crossref
Wachiraporn Noracharttiyapot, Yoko Nagai, Tsutomu Matsubara, Masaaki Miyata, Miki Shimada, Kiyoshi Nagata & Yasushi Yamazoe. (2006) Construction of Several Human-derived Stable Cell Lines Displaying Distinct Profiles of CYP3A4 Induction. Drug Metabolism and Pharmacokinetics 21:2, pages 99-108.
Crossref
Crossref
Mohammed Al-Dosari, Guisheng Zhang, Joseph E. Knapp & Dexi Liu. (2006) Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver. Biochemical and Biophysical Research Communications 339:2, pages 673-678.
Crossref
Crossref
Neil B. Sandson, Scott C. Armstrong & Kelly L. Cozza. (2005) An Overview of Psychotropic Drug-Drug Interactions. Psychosomatics 46:5, pages 464-494.
Crossref
Crossref
Tony Antoniou & Alice L Tseng. (2005) Interactions Between Antiretrovirals and Antineoplastic Drug Therapy. Clinical Pharmacokinetics 44:2, pages 111-145.
Crossref
Crossref
Nick Plant. (2004) Strategies for using in vitro screens in drug metabolism. Drug Discovery Today 9:7, pages 328-336.
Crossref
Crossref
Mee Ryung Ahn, Dae-Kee Kim & Yhun Yhong Sheen. (2004) Trichostatin a, a histone deacetylase inhibitor stimulateCYP3A4 proximal promoter activity in hepa-I cells. Archives of Pharmacal Research 27:4, pages 415-421.
Crossref
Crossref
Ja Young Kim, Mee Ryung Ahn, Dae-Kee Kim & Yhun Yhong Sheen. (2004) Histone deacetylase inhibitor stimulateCYP3A4 proximal promoter activity in hepg2 cells. Archives of Pharmacal Research 27:4.
Crossref
Crossref
Lauretta M.S Chan, Simon Lowes & Barry H Hirst. (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. European Journal of Pharmaceutical Sciences 21:1, pages 25-51.
Crossref
Crossref
J. M. Pascussi, Z. Dvorák, S. Gerbal-Chaloin, E. Assenat, L. Drocourt, P. Maurel & M. J. Vilarem. 2004. Transcription Factors. Transcription Factors
409
435
.
Martine Daujat, Gérard Fabre, Marie-José Vilarem, Lydiane Pichard-Garcia, Lionel Drocourt, Jean-Marc Pascussi, Patrick Maurel, Sylvie Klieber, Martine Bourrié, Sabine Gerbal-Chaloin, François Guillou & François Torreilles. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
337
374
.
J. Fred Pritchard, Malle Jurima-Romet, Mark L. J. Reimer, Elisabeth Mortimer, Brenda Rolfe & Mitchell N. Cayen. (2003) Making Better Drugs: Decision Gates in Non-Clinical Drug Development. Nature Reviews Drug Discovery 2:7, pages 542-553.
Crossref
Crossref
Weisheng Zhang, Anthony Purchio, Kevin Chen, Stacy M Burns, Christopher H Contag & Pamela R Contag. (2003) In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors. Biochemical Pharmacology 65:11, pages 1889-1896.
Crossref
Crossref
Solveigh Krusekopf, Ivar Roots & Ullrich Kleeberg. (2003) Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European Journal of Pharmacology 466:1-2, pages 7-12.
Crossref
Crossref
J.M. Pascussi, S. Gerbal-Chaloin, L. Drocourt, P. Maurel & M.J. Vilarem. (2003) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochimica et Biophysica Acta (BBA) - General Subjects 1619:3, pages 243-253.
Crossref
Crossref
Tatsuhiro Usui, Yukiya Saitoh & Fusao Komada. (2003) Induction of CYP3As in HepG2 Cells by Several Drugs. Association between Induction of CYP3A4 and Expression of Glucocorticoid Receptor.. Biological and Pharmaceutical Bulletin 26:4, pages 510-517.
Crossref
Crossref
Pierre Kremers. (2003)
In vitro
Tests for Predicting Drug‐Drug Interactions: The Need for Validated Procedures
. Pharmacology & Toxicology 91:5, pages 209-217.
Crossref
Crossref
D.F.V. Lewis, M.S. Ogg, P.S. Goldfarb & G.G. Gibson. (2002) Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor α (hERα) LBD: quantitative structure–activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement. The Journal of Steroid Biochemistry and Molecular Biology 82:2-3, pages 195-199.
Crossref
Crossref
Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson & Nick Plant. (2002) Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element. Drug Metabolism and Disposition 30:9, pages 1029-1034.
Crossref
Crossref
D.F.V. Lewis, M.N. Jacobs, M. Dickins & B.G. Lake. (2002) Quantitative structure–activity relationships for inducers of cytochromes P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 families. Toxicology 176:1-2, pages 51-57.
Crossref
Crossref
Firoozeh S. Salek, Kristin L. Bigos & Patricia Dowley Kroboth. (2013) The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies. The Journal of Clinical Pharmacology 42:3, pages 247-266.
Crossref
Crossref
Yasufumi Sawada, Sayuri Takedomi, Hirotami Matsuo, Katsuhiro Yamano, Tatsuji Iga & Hisakazu Ohtani. (2002) Effects of Single and Repeated Treatment with Itraconazole on the Pharmacokinetics of Midazolam in Rats. Drug Metabolism and Pharmacokinetics 17:4, pages 275-283.
Crossref
Crossref
Jean‐Marc Pascussi, Lionel Drocourt, Sabine Gerbal‐Chaloin, Jean‐Michel Fabre, Patrick Maurel & Marie‐José Vilarem. (2002)
Dual effect of dexamethasone on
CYP3A4
gene expression in human hepatocytes
. European Journal of Biochemistry 268:24, pages 6346-6358.
Crossref
Crossref
A.David Rodrigues & Jiunn H Lin. (2001) Screening of drug candidates for their drug–drug interaction potential. Current Opinion in Chemical Biology 5:4, pages 396-401.
Crossref
Crossref
Marc Bertrand, Peter Jackson & Bernard Walther. (2000) Rapid assessment of drug metabolism in the drug discovery process. European Journal of Pharmaceutical Sciences 11, pages S61-S72.
Crossref
Crossref
D.A Smith. (2000) Induction and drug development. European Journal of Pharmaceutical Sciences 11:3, pages 185-189.
Crossref
Crossref
Ronald E. White. (2000) High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery. Annual Review of Pharmacology and Toxicology 40:1, pages 133-157.
Crossref
Crossref
Nick J. Plant, Malcolm Ogg, Martin Crowder & G.Gordon Gibson. (2000) Control and Statistical Analysis of in Vitro Reporter Gene Assays. Analytical Biochemistry 278:2, pages 170-174.
Crossref
Crossref
Anna Westlind, Lena Löfberg, Niclas Tindberg, Tommy B. Andersson & Magnus Ingelman-Sundberg. (1999) Interindividual Differences in Hepatic Expression of CYP3A4: Relationship to Genetic Polymorphism in the 5′-Upstream Regulatory Region. Biochemical and Biophysical Research Communications 259:1, pages 201-205.
Crossref
Crossref